{
    "xml": "<topic id=\"PHP5874\" outputclass=\"drug\" rev=\"1.11\" type=\"drug\" namespace=\"/drugs/folic-acid\" basename=\"folic-acid\" title=\"FOLIC ACID\">\n<title>FOLIC ACID</title>\n<body>\r\n<p outputclass=\"interactionsLinks\"> List of individual interactants: <xref format=\"dita\" href=\"#bnf_int_767\" namespace=\"/interactions/list-of-drug-interactions/folates/folic-acid\">Folic Acid</xref>\n</p>\n<data name=\"vtmid\">6247001</data>\n<data name=\"classifications\">\n<data name=\"classification\">\n<data name=\"drugClassification\">\n<xref format=\"dita\" scope=\"local\" type=\"drugClassification\" href=\"#_251481106\" title=\"Folates\">Folates</xref>\n</data>\n</data>\n</data>\n<data name=\"primaryDomainOfEffect\">\n<data name=\"domainOfEffect\">  </data>\n</data>\r\n</body>\n<topic id=\"PHP42009\" outputclass=\"indicationsAndDose\" rev=\"1.26\" parent=\"/drugs/folic-acid\">\n<title>Indications and dose</title>\n<body>\n<section outputclass=\"indicationAndDoseGroup\">\n<sectiondiv outputclass=\"therapeuticIndications\">\n<p outputclass=\"therapeuticIndication\">Folate-deficient megaloblastic anaemia</p>\n</sectiondiv>\n<p outputclass=\"routesOfAdministration\">By mouth</p>\n<ul outputclass=\"patientGroups\">\n<li outputclass=\"patientGroup child\">\n<p>Child 1&#8211;11 months</p>\n<p>Initially 500&#8239;micrograms/kg once daily (max. per dose 5&#8239;mg) for up to 4 months, in malabsorption states, doses up to 10&#8239;mg daily may be required.</p>\n</li>\n<li outputclass=\"patientGroup child\">\n<p>Child 1&#8211;17 years</p>\n<p>5&#8239;mg daily for 4 months (until term in pregnant women), in malabsorption states, doses up to 15&#8239;mg daily may be required.</p>\n</li>\n<li outputclass=\"patientGroup adult\">\n<p>Adult</p>\n<p>5&#8239;mg daily for 4 months (until term in pregnant women), in malabsorption states, doses up to 15&#8239;mg daily may be required.</p>\n</li>\n</ul>\n</section>\n<section outputclass=\"indicationAndDoseGroup\">\n<sectiondiv outputclass=\"therapeuticIndications\">\n<p outputclass=\"therapeuticIndication\">Prevention of neural tube defects (women at a low risk of conceiving a child with a neural tube defect)</p>\n</sectiondiv>\n<p outputclass=\"routesOfAdministration\">By mouth</p>\n<ul outputclass=\"patientGroups\">\n<li outputclass=\"patientGroup adult\">\n<p>Adult</p>\n<p>400&#8239;micrograms daily, to be taken before conception and until week 12 of pregnancy.</p>\n</li>\n</ul>\n</section>\n<section outputclass=\"indicationAndDoseGroup\">\n<sectiondiv outputclass=\"therapeuticIndications\">\n<p outputclass=\"therapeuticIndication\">Prevention of neural tube defects (women at low risk who have not been taking folic acid and who suspect they are pregnant)</p>\n</sectiondiv>\n<p outputclass=\"routesOfAdministration\">By mouth</p>\n<ul outputclass=\"patientGroups\">\n<li outputclass=\"patientGroup adult\">\n<p>Adult</p>\n<p>400&#8239;micrograms daily, to be taken at once and continued until week 12 of pregnancy.</p>\n</li>\n</ul>\n</section>\n<section outputclass=\"indicationAndDoseGroup\">\n<sectiondiv outputclass=\"therapeuticIndications\">\n<p outputclass=\"therapeuticIndication\">Prevention of neural tube defects (women in the high-risk group who wish to become pregnant or who are at risk of becoming pregnant)</p>\n</sectiondiv>\n<p outputclass=\"routesOfAdministration\">By mouth</p>\n<ul outputclass=\"patientGroups\">\n<li outputclass=\"patientGroup adult\">\n<p>Adult</p>\n<p>5&#8239;mg daily until week 12 of pregnancy.</p>\n</li>\n</ul>\n</section>\n<section outputclass=\"indicationAndDoseGroup\">\n<sectiondiv outputclass=\"therapeuticIndications\">\n<p outputclass=\"therapeuticIndication\">Prevention of neural tube defects (women with sickle-cell disease)</p>\n</sectiondiv>\n<p outputclass=\"routesOfAdministration\">By mouth</p>\n<ul outputclass=\"patientGroups\">\n<li outputclass=\"patientGroup adult\">\n<p>Adult</p>\n<p>5&#8239;mg daily, patient should continue taking their normal dose of folic acid 5&#8239;mg daily (or to increase the dose to 5&#8239;mg daily) and continue this throughout pregnancy.</p>\n</li>\n</ul>\n</section>\n<section outputclass=\"indicationAndDoseGroup\">\n<sectiondiv outputclass=\"therapeuticIndications\">\n<p outputclass=\"therapeuticIndication\">Prevention of methotrexate-induced side-effects in rheumatic disease</p>\n</sectiondiv>\n<p outputclass=\"routesOfAdministration\">By mouth</p>\n<ul outputclass=\"patientGroups\">\n<li outputclass=\"patientGroup adult\">\n<p>Adult</p>\n<p>5&#8239;mg once weekly, dose to be taken on a different day to methotrexate dose.</p>\n</li>\n</ul>\n</section>\n<section outputclass=\"indicationAndDoseGroup\">\n<sectiondiv outputclass=\"therapeuticIndications\">\n<p outputclass=\"therapeuticIndication\">Prevention of methotrexate side-effects in severe Crohn's disease</p>\n<p outputclass=\"therapeuticIndication\">Prevention of methotrexate side-effects in severe psoriasis</p>\n</sectiondiv>\n<p outputclass=\"routesOfAdministration\">By mouth</p>\n<ul outputclass=\"patientGroups\">\n<li outputclass=\"patientGroup adult\">\n<p>Adult</p>\n<p>5&#8239;mg once weekly, dose to be taken on a different day to methotrexate dose.</p>\n</li>\n</ul>\n</section>\n<section outputclass=\"indicationAndDoseGroup\">\n<sectiondiv outputclass=\"therapeuticIndications\">\n<p outputclass=\"therapeuticIndication\">Prophylaxis in chronic haemolytic states</p>\n</sectiondiv>\n<p outputclass=\"routesOfAdministration\">By mouth</p>\n<ul outputclass=\"patientGroups\">\n<li outputclass=\"patientGroup adult\">\n<p>Adult</p>\n<p>5&#8239;mg every 1&#8211;7&#8239;days, frequency dependent on underlying disease.</p>\n</li>\n</ul>\n</section>\n<section outputclass=\"indicationAndDoseGroup\">\n<sectiondiv outputclass=\"therapeuticIndications\">\n<p outputclass=\"therapeuticIndication\">Prophylaxis of folate deficiency in dialysis</p>\n</sectiondiv>\n<p outputclass=\"routesOfAdministration\">By mouth</p>\n<ul outputclass=\"patientGroups\">\n<li outputclass=\"patientGroup child\">\n<p>Child 1&#8211;11 years</p>\n<p>250&#8239;micrograms/kg once daily (max. per dose 10&#8239;mg).</p>\n</li>\n<li outputclass=\"patientGroup child\">\n<p>Child 12&#8211;17 years</p>\n<p>5&#8211;10&#8239;mg once daily.</p>\n</li>\n<li outputclass=\"patientGroup adult\">\n<p>Adult</p>\n<p>5&#8239;mg every 1&#8211;7&#8239;days.</p>\n</li>\n</ul>\n</section>\n<section outputclass=\"indicationAndDoseGroup\">\n<sectiondiv outputclass=\"therapeuticIndications\">\n<p outputclass=\"therapeuticIndication\">Haemolytic anaemia</p>\n<p outputclass=\"therapeuticIndication\">Metabolic disorders</p>\n</sectiondiv>\n<p outputclass=\"routesOfAdministration\">By mouth</p>\n<ul outputclass=\"patientGroups\">\n<li outputclass=\"patientGroup child\">\n<p>Child 1 month&#8211;11 years</p>\n<p>2.5&#8211;5&#8239;mg once daily.</p>\n</li>\n<li outputclass=\"patientGroup child\">\n<p>Child 12&#8211;17 years</p>\n<p>5&#8211;10&#8239;mg once daily.</p>\n</li>\n<li outputclass=\"patientGroup adult\">\n<p>Adult 18 years</p>\n<p>5&#8211;10&#8239;mg once daily.</p>\n</li>\n</ul>\n</section>\n</body>\n</topic>\n<topic id=\"PHP41980\" outputclass=\"unlicensedUse\" rev=\"1.13\" parent=\"/drugs/folic-acid\">\n<title>Unlicensed use</title>\n<body>\n<section>\n<sectiondiv>\n<p outputclass=\"specificity\">In children</p>\n<p>Unlicensed for limiting methotrexate toxicity.</p>\n</sectiondiv>\n<sectiondiv>\n<p outputclass=\"specificity\">In adults</p>\n<p>Not licensed for prevention of methotrexate-induced side-effects in severe Crohn's disease.</p>\n<p>Not licensed for prevention of methotrexate-induced side-effects in rheumatic disease.</p>\n<p>Not licensed for prevention of methotrexate-induced side-effects in severe psoriasis.</p>\n</sectiondiv>\n</section>\n</body>\n</topic>\n<topic id=\"PHP42043\" outputclass=\"cautions\" rev=\"1.12\" parent=\"/drugs/folic-acid\">\n<title>Cautions</title>\n<body>\n<section outputclass=\"cautions\">\n<p>\n<ph outputclass=\"caution\">Should never be given alone for pernicious anaemia (may precipitate subacute combined degeneration of the spinal cord)</ph>\n</p>\n</section>\n</body>\n</topic>\n<topic id=\"PHP42006\" outputclass=\"interactions\" rev=\"1.7\" parent=\"/drugs/folic-acid\">\n<title>Interactions</title>\n<body>\n<section outputclass=\"general\">\n<sectiondiv>\n<p>Appendix 1 (folates).</p>\n</sectiondiv>\n</section>\n</body>\n</topic>\n<topic id=\"PHP41989\" outputclass=\"sideEffects\" rev=\"1.8\" parent=\"/drugs/folic-acid\">\n<title>Side-effects</title>\n<body>\n<section outputclass=\"generalSideEffects\">\n<sectiondiv outputclass=\"frequencies\">\n<sectiondiv outputclass=\"rare\">\n<p outputclass=\"title\">Rare</p>\n<p outputclass=\"sideEffects\">\n<ph outputclass=\"sideEffect\">Gastro-intestinal disturbances</ph>\n</p>\n</sectiondiv>\n</sectiondiv>\n</section>\n</body>\n</topic>\n<topic id=\"PHP42001\" outputclass=\"patientAndCarerAdvice\" rev=\"1.13\" parent=\"/drugs/folic-acid\">\n<title>Patient and carer advice</title>\n<body>\r\n\r\n\r\n<section outputclass=\"patientResources\">\r\n<sectiondiv>\r\n<p outputclass=\"specificity\">In children</p>\r\n<p outputclass=\"title\">Medicines for Children leaflet: Folic acid for megaloblastic anaemia caused by folate deficiency and haemolytic anaemia</p>\r\n<p>\n<xref format=\"html\" href=\"http://www.medicinesforchildren.org.uk/folic-acid-megaloblastic-anaemia-caused-folate-deficiency-and-haemolytic-anaemia\">www.medicinesforchildren.org.uk/folic-acid-megaloblastic-anaemia-caused-folate-deficiency-and-haemolytic-anaemia</xref>\n</p>\n</sectiondiv>\n</section>\r\n\r\n\r\n\r\n\r\n\r\n\r\n</body>\n</topic>\n<topic id=\"PHP41959\" outputclass=\"exceptionsToLegalCategory\" rev=\"1.12\" parent=\"/drugs/folic-acid\">\n<title>Exceptions to legal category</title>\n<body>\n<section>\n<sectiondiv>\n<p outputclass=\"specificity\">With <ph outputclass=\"route\">oral</ph> use</p>\n<p>Can be sold to the public provided daily doses do not exceed 500&#8239;micrograms.</p>\n</sectiondiv>\n</section>\n</body>\n</topic>\n<topic id=\"PHP5874-medicinalForms\" outputclass=\"medicinalForms\" parent=\"/drugs/folic-acid\">\n<title>Medicinal forms</title>\n<body>\n<section outputclass=\"licensingVariationStatement\">\n<p>There can be variation in the licensing of different medicines containing the same drug.</p>\n</section>\n<p>Forms available from special-order manufacturers include: solution for injection, oral suspension, oral solution, capsule</p>\n</body>\n</topic>\n<parents>\n<xref format=\"dita\" scope=\"local\" type=\"drugs\" href=\"#drugs\" title=\"Drugs\" namespace=\"/drugs\">Drugs</xref>\n</parents>\n<children>\n<xref format=\"dita\" scope=\"local\" type=\"medicinalForm\" href=\"#PHP74744\" title=\"Tablet\" namespace=\"/drugs/folic-acid/tablet\">Tablet</xref>\n<xref format=\"dita\" scope=\"local\" type=\"medicinalForm\" href=\"#PHP74751\" title=\"Oral solution\" namespace=\"/drugs/folic-acid/oral-solution\">Oral solution</xref>\n</children>\n<backlinks>\n<xref format=\"dita\" scope=\"local\" type=\"drug\" href=\"#PHP3641\" namespace=\"/drugs/dapsone\" title=\"DAPSONE\" count=\"1\" rel=\"backlink\">DAPSONE</xref>\n<xref format=\"dita\" scope=\"local\" type=\"drug\" href=\"#PHP87987\" namespace=\"/drugs/ferrous-sulfate-with-folic-acid\" title=\"FERROUS SULFATE WITH FOLIC ACID\" count=\"1\" rel=\"backlink\">FERROUS SULFATE WITH FOLIC ACID</xref>\n<xref format=\"dita\" scope=\"local\" type=\"drug\" href=\"#PHP87988\" namespace=\"/drugs/ferrous-fumarate-with-folic-acid\" title=\"FERROUS FUMARATE WITH FOLIC ACID\" count=\"1\" rel=\"backlink\">FERROUS FUMARATE WITH FOLIC ACID</xref>\n<xref format=\"dita\" scope=\"local\" type=\"drugClassifications\" href=\"#PHP106980\" namespace=\"/drug-classifications\" title=\"Drug classifications\" count=\"1\" rel=\"backlink\">Drug classifications</xref>\n<xref format=\"dita\" scope=\"local\" type=\"treatmentSummary\" href=\"#PHP78102\" namespace=\"/treatment-summaries/malaria-prophylaxis\" title=\"Malaria, prophylaxis\" count=\"1\" rel=\"backlink\">Malaria, prophylaxis</xref>\n<xref format=\"dita\" scope=\"local\" type=\"treatmentSummary\" href=\"#PHP78151\" namespace=\"/treatment-summaries/immune-response\" title=\"Immune response\" count=\"2\" rel=\"backlink\">Immune response</xref>\n<xref format=\"dita\" scope=\"local\" type=\"treatmentSummary\" href=\"#PHP78195\" namespace=\"/treatment-summaries/vitamins\" title=\"Vitamins\" count=\"1\" rel=\"backlink\">Vitamins</xref>\n<xref format=\"dita\" scope=\"local\" type=\"treatmentSummary\" href=\"#PHP78316\" namespace=\"/treatment-summaries/inflammatory-bowel-disease\" title=\"Inflammatory bowel disease\" count=\"2\" rel=\"backlink\">Inflammatory bowel disease</xref>\n<xref format=\"dita\" scope=\"local\" type=\"treatmentSummary\" href=\"#PHP78375\" namespace=\"/treatment-summaries/eczema-and-psoriasis-drugs-affecting-the-immune-response\" title=\"Eczema and psoriasis, drugs affecting the immune response\" count=\"3\" rel=\"backlink\">Eczema and psoriasis, drugs affecting the immune response</xref>\n<xref format=\"dita\" scope=\"local\" type=\"treatmentSummary\" href=\"#PHP78421\" namespace=\"/treatment-summaries/rheumatic-disease-suppressing-drugs\" title=\"Rheumatic disease, suppressing drugs\" count=\"1\" rel=\"backlink\">Rheumatic disease, suppressing drugs</xref>\n<xref format=\"dita\" scope=\"local\" type=\"treatmentSummary\" href=\"#PHP78510\" namespace=\"/treatment-summaries/neural-tube-defects-prevention-in-pregnancy\" title=\"Neural tube defects (prevention in pregnancy)\" count=\"7\" rel=\"backlink\">Neural tube defects (prevention in pregnancy)</xref>\n<xref format=\"dita\" scope=\"local\" type=\"treatmentSummary\" href=\"#PHP78524\" namespace=\"/treatment-summaries/intravenous-nutrition\" title=\"Intravenous nutrition\" count=\"1\" rel=\"backlink\">Intravenous nutrition</xref>\n<xref format=\"dita\" scope=\"local\" type=\"treatmentSummary\" href=\"#PHP78590\" namespace=\"/treatment-summaries/anaemias\" title=\"Anaemias\" count=\"8\" rel=\"backlink\">Anaemias</xref>\n</backlinks>\n<links>\n<xref format=\"dita\" scope=\"local\" type=\"interaction\" href=\"#bnf_int_767\" namespace=\"/interactions/list-of-drug-interactions/folates/folic-acid\" title=\"Folic Acid\" count=\"1\" rel=\"link\">Folic Acid</xref>\n<xref format=\"dita\" scope=\"local\" type=\"#drugs\" href=\"#drugs\" namespace=\"/drugs\" title=\"Drugs\" count=\"1\" rel=\"link\">Drugs</xref>\n<xref format=\"dita\" scope=\"local\" type=\"medicinalForm\" href=\"#PHP74744\" namespace=\"/drugs/folic-acid/tablet\" title=\"Tablet\" count=\"1\" rel=\"link\">Tablet</xref>\n<xref format=\"dita\" scope=\"local\" type=\"medicinalForm\" href=\"#PHP74751\" namespace=\"/drugs/folic-acid/oral-solution\" title=\"Oral solution\" count=\"1\" rel=\"link\">Oral solution</xref>\n</links>\n</topic>",
    "id": "PHP5874",
    "outputclass": "drug",
    "rev": "1.11",
    "type": "drug",
    "namespace": "/drugs/folic-acid",
    "basename": "folic-acid",
    "title": "FOLIC ACID",
    "interactants": [
        {
            "id": "bnf_int_767",
            "label": "Folic Acid"
        }
    ],
    "vtmid": "6247001",
    "drugClassification": [
        "Folates"
    ],
    "primaryDomainOfEffect": {
        "": {
            "domain": "",
            "therapeuticUses": {}
        }
    },
    "indicationsAndDoses": {
        "indicationAndDoseGroups": [
            {
                "indications": [
                    {
                        "textContent": "Folate-deficient megaloblastic anaemia",
                        "html": "Folate-deficient megaloblastic anaemia"
                    }
                ],
                "specificity": {
                    "routes": [
                        "mouth"
                    ],
                    "textContent": "By mouth",
                    "html": "By mouth"
                },
                "child": [
                    {
                        "textContent": "Initially 500 micrograms/kg once daily (max. per dose 5 mg) for up to 4 months, in malabsorption states, doses up to 10 mg daily may be required.",
                        "html": "<p>Initially 500&#8239;micrograms/kg once daily (max. per dose 5&#8239;mg) for up to 4 months, in malabsorption states, doses up to 10&#8239;mg daily may be required.</p>",
                        "ageGroup": "1&#8211;11 months"
                    },
                    {
                        "textContent": "5 mg daily for 4 months (until term in pregnant women), in malabsorption states, doses up to 15 mg daily may be required.",
                        "html": "<p>5&#8239;mg daily for 4 months (until term in pregnant women), in malabsorption states, doses up to 15&#8239;mg daily may be required.</p>",
                        "ageGroup": "1&#8211;17 years"
                    }
                ],
                "adult": [
                    {
                        "textContent": "5 mg daily for 4 months (until term in pregnant women), in malabsorption states, doses up to 15 mg daily may be required.",
                        "html": "<p>5&#8239;mg daily for 4 months (until term in pregnant women), in malabsorption states, doses up to 15&#8239;mg daily may be required.</p>"
                    }
                ]
            },
            {
                "indications": [
                    {
                        "textContent": "Prevention of neural tube defects (women at a low risk of conceiving a child with a neural tube defect)",
                        "html": "Prevention of neural tube defects (women at a low risk of conceiving a child with a neural tube defect)"
                    }
                ],
                "specificity": {
                    "routes": [
                        "mouth"
                    ],
                    "textContent": "By mouth",
                    "html": "By mouth"
                },
                "adult": [
                    {
                        "textContent": "400 micrograms daily, to be taken before conception and until week 12 of pregnancy.",
                        "html": "<p>400&#8239;micrograms daily, to be taken before conception and until week 12 of pregnancy.</p>"
                    }
                ]
            },
            {
                "indications": [
                    {
                        "textContent": "Prevention of neural tube defects (women at low risk who have not been taking folic acid and who suspect they are pregnant)",
                        "html": "Prevention of neural tube defects (women at low risk who have not been taking folic acid and who suspect they are pregnant)"
                    }
                ],
                "specificity": {
                    "routes": [
                        "mouth"
                    ],
                    "textContent": "By mouth",
                    "html": "By mouth"
                },
                "adult": [
                    {
                        "textContent": "400 micrograms daily, to be taken at once and continued until week 12 of pregnancy.",
                        "html": "<p>400&#8239;micrograms daily, to be taken at once and continued until week 12 of pregnancy.</p>"
                    }
                ]
            },
            {
                "indications": [
                    {
                        "textContent": "Prevention of neural tube defects (women in the high-risk group who wish to become pregnant or who are at risk of becoming pregnant)",
                        "html": "Prevention of neural tube defects (women in the high-risk group who wish to become pregnant or who are at risk of becoming pregnant)"
                    }
                ],
                "specificity": {
                    "routes": [
                        "mouth"
                    ],
                    "textContent": "By mouth",
                    "html": "By mouth"
                },
                "adult": [
                    {
                        "textContent": "5 mg daily until week 12 of pregnancy.",
                        "html": "<p>5&#8239;mg daily until week 12 of pregnancy.</p>"
                    }
                ]
            },
            {
                "indications": [
                    {
                        "textContent": "Prevention of neural tube defects (women with sickle-cell disease)",
                        "html": "Prevention of neural tube defects (women with sickle-cell disease)"
                    }
                ],
                "specificity": {
                    "routes": [
                        "mouth"
                    ],
                    "textContent": "By mouth",
                    "html": "By mouth"
                },
                "adult": [
                    {
                        "textContent": "5 mg daily, patient should continue taking their normal dose of folic acid 5 mg daily (or to increase the dose to 5 mg daily) and continue this throughout pregnancy.",
                        "html": "<p>5&#8239;mg daily, patient should continue taking their normal dose of folic acid 5&#8239;mg daily (or to increase the dose to 5&#8239;mg daily) and continue this throughout pregnancy.</p>"
                    }
                ]
            },
            {
                "indications": [
                    {
                        "textContent": "Prevention of methotrexate-induced side-effects in rheumatic disease",
                        "html": "Prevention of methotrexate-induced side-effects in rheumatic disease"
                    }
                ],
                "specificity": {
                    "routes": [
                        "mouth"
                    ],
                    "textContent": "By mouth",
                    "html": "By mouth"
                },
                "adult": [
                    {
                        "textContent": "5 mg once weekly, dose to be taken on a different day to methotrexate dose.",
                        "html": "<p>5&#8239;mg once weekly, dose to be taken on a different day to methotrexate dose.</p>"
                    }
                ]
            },
            {
                "indications": [
                    {
                        "textContent": "Prevention of methotrexate side-effects in severe Crohn's disease",
                        "html": "Prevention of methotrexate side-effects in severe Crohn's disease"
                    },
                    {
                        "textContent": "Prevention of methotrexate side-effects in severe psoriasis",
                        "html": "Prevention of methotrexate side-effects in severe psoriasis"
                    }
                ],
                "specificity": {
                    "routes": [
                        "mouth"
                    ],
                    "textContent": "By mouth",
                    "html": "By mouth"
                },
                "adult": [
                    {
                        "textContent": "5 mg once weekly, dose to be taken on a different day to methotrexate dose.",
                        "html": "<p>5&#8239;mg once weekly, dose to be taken on a different day to methotrexate dose.</p>"
                    }
                ]
            },
            {
                "indications": [
                    {
                        "textContent": "Prophylaxis in chronic haemolytic states",
                        "html": "Prophylaxis in chronic haemolytic states"
                    }
                ],
                "specificity": {
                    "routes": [
                        "mouth"
                    ],
                    "textContent": "By mouth",
                    "html": "By mouth"
                },
                "adult": [
                    {
                        "textContent": "5 mg every 1&#8211;7 days, frequency dependent on underlying disease.",
                        "html": "<p>5&#8239;mg every 1&#8211;7&#8239;days, frequency dependent on underlying disease.</p>"
                    }
                ]
            },
            {
                "indications": [
                    {
                        "textContent": "Prophylaxis of folate deficiency in dialysis",
                        "html": "Prophylaxis of folate deficiency in dialysis"
                    }
                ],
                "specificity": {
                    "routes": [
                        "mouth"
                    ],
                    "textContent": "By mouth",
                    "html": "By mouth"
                },
                "child": [
                    {
                        "textContent": "250 micrograms/kg once daily (max. per dose 10 mg).",
                        "html": "<p>250&#8239;micrograms/kg once daily (max. per dose 10&#8239;mg).</p>",
                        "ageGroup": "1&#8211;11 years"
                    },
                    {
                        "textContent": "5&#8211;10 mg once daily.",
                        "html": "<p>5&#8211;10&#8239;mg once daily.</p>",
                        "ageGroup": "12&#8211;17 years"
                    }
                ],
                "adult": [
                    {
                        "textContent": "5 mg every 1&#8211;7 days.",
                        "html": "<p>5&#8239;mg every 1&#8211;7&#8239;days.</p>"
                    }
                ]
            },
            {
                "indications": [
                    {
                        "textContent": "Haemolytic anaemia",
                        "html": "Haemolytic anaemia"
                    },
                    {
                        "textContent": "Metabolic disorders",
                        "html": "Metabolic disorders"
                    }
                ],
                "specificity": {
                    "routes": [
                        "mouth"
                    ],
                    "textContent": "By mouth",
                    "html": "By mouth"
                },
                "child": [
                    {
                        "textContent": "2.5&#8211;5 mg once daily.",
                        "html": "<p>2.5&#8211;5&#8239;mg once daily.</p>",
                        "ageGroup": "1 month&#8211;11 years"
                    },
                    {
                        "textContent": "5&#8211;10 mg once daily.",
                        "html": "<p>5&#8211;10&#8239;mg once daily.</p>",
                        "ageGroup": "12&#8211;17 years"
                    }
                ],
                "adult": [
                    {
                        "textContent": "5&#8211;10 mg once daily.",
                        "html": "<p>5&#8211;10&#8239;mg once daily.</p>",
                        "ageGroup": "18 years"
                    }
                ]
            }
        ]
    },
    "unlicensedUse": {
        "unlicensedUse": [
            {
                "type": "unlicensedUse",
                "specificity": {
                    "textContent": "In children",
                    "html": "In children",
                    "patientType": "children"
                },
                "textContent": "Unlicensed for limiting methotrexate toxicity.",
                "html": "<p>Unlicensed for limiting methotrexate toxicity.</p>"
            },
            {
                "type": "unlicensedUse",
                "specificity": {
                    "textContent": "In adults",
                    "html": "In adults",
                    "patientType": "adults"
                },
                "textContent": "Not licensed for prevention of methotrexate-induced side-effects in severe Crohn's disease.\n\nNot licensed for prevention of methotrexate-induced side-effects in rheumatic disease.\n\nNot licensed for prevention of methotrexate-induced side-effects in severe psoriasis.",
                "html": "<p>Not licensed for prevention of methotrexate-induced side-effects in severe Crohn's disease.</p><p>Not licensed for prevention of methotrexate-induced side-effects in rheumatic disease.</p><p>Not licensed for prevention of methotrexate-induced side-effects in severe psoriasis.</p>"
            }
        ]
    },
    "cautions": {
        "cautions": [
            {
                "type": "cautions",
                "textContent": "Should never be given alone for pernicious anaemia (may precipitate subacute combined degeneration of the spinal cord)",
                "html": "Should never be given alone for pernicious anaemia (may precipitate subacute combined degeneration of the spinal cord)"
            }
        ]
    },
    "interactions": {
        "general": [
            {
                "type": "general",
                "textContent": "Appendix 1 (folates).",
                "html": "<p>Appendix 1 (folates).</p>"
            }
        ]
    },
    "sideEffects": {
        "general": {
            "frequencies": {
                "rare": [
                    {
                        "type": "rare",
                        "textContent": "Gastro-intestinal disturbances",
                        "html": "Gastro-intestinal disturbances",
                        "frequency": "rare",
                        "specificity": {
                            "textContent": "Rare",
                            "html": "Rare"
                        }
                    }
                ]
            }
        }
    },
    "patientAndCarerAdvice": {
        "patientResources": [
            {
                "type": "patientResources",
                "references": [
                    {
                        "id": "http://www.medicinesforchildren.org.uk/folic-acid-megaloblastic-anaemia-caused-folate-deficiency-and-haemolytic-anaemia",
                        "label": "www.medicinesforchildren.org.uk/folic-acid-megaloblastic-anaemia-caused-folate-deficiency-and-haemolytic-anaemia"
                    }
                ],
                "specificity": {
                    "textContent": "In children",
                    "html": "In children",
                    "patientType": "children"
                },
                "title": "Medicines for Children leaflet: Folic acid for megaloblastic anaemia caused by folate deficiency and haemolytic anaemia",
                "textContent": "www.medicinesforchildren.org.uk/folic-acid-megaloblastic-anaemia-caused-folate-deficiency-and-haemolytic-anaemia",
                "html": "<p>\n<xref format=\"html\" href=\"http://www.medicinesforchildren.org.uk/folic-acid-megaloblastic-anaemia-caused-folate-deficiency-and-haemolytic-anaemia\">www.medicinesforchildren.org.uk/folic-acid-megaloblastic-anaemia-caused-folate-deficiency-and-haemolytic-anaemia</xref>\n</p>"
            }
        ]
    },
    "exceptionsToLegalCategory": {
        "exceptionsToLegalCategory": [
            {
                "type": "exceptionsToLegalCategory",
                "specificity": {
                    "textContent": "With oral use",
                    "html": "With <ph outputclass=\"route\">oral</ph> use",
                    "routes": [
                        "oral"
                    ]
                },
                "textContent": "Can be sold to the public provided daily doses do not exceed 500 micrograms.",
                "html": "<p>Can be sold to the public provided daily doses do not exceed 500&#8239;micrograms.</p>"
            }
        ]
    },
    "medicinalForms": {
        "licensingVariationStatement": [
            {
                "type": "licensingVariationStatement",
                "textContent": "There can be variation in the licensing of different medicines containing the same drug.",
                "html": "<p>There can be variation in the licensing of different medicines containing the same drug.</p>"
            }
        ],
        "availableForms": {
            "before": "Forms available from special-order manufacturers include",
            "forms": [
                "solution for injection",
                "oral suspension",
                "oral solution",
                "capsule"
            ]
        }
    },
    "children": {
        "medicinalForm": [
            {
                "id": "PHP74744",
                "label": "Tablet",
                "type": "medicinalForm"
            },
            {
                "id": "PHP74751",
                "label": "Oral solution",
                "type": "medicinalForm"
            }
        ]
    },
    "backlinks": {
        "drug": [
            {
                "id": "PHP3641",
                "label": "DAPSONE",
                "type": "drug"
            },
            {
                "id": "PHP87987",
                "label": "FERROUS SULFATE WITH FOLIC ACID",
                "type": "drug"
            },
            {
                "id": "PHP87988",
                "label": "FERROUS FUMARATE WITH FOLIC ACID",
                "type": "drug"
            }
        ],
        "drugClassifications": [
            {
                "id": "PHP106980",
                "label": "Drug classifications",
                "type": "drugClassifications"
            }
        ],
        "treatmentSummary": [
            {
                "id": "PHP78102",
                "label": "Malaria, prophylaxis",
                "type": "treatmentSummary"
            },
            {
                "id": "PHP78151",
                "label": "Immune response",
                "type": "treatmentSummary"
            },
            {
                "id": "PHP78195",
                "label": "Vitamins",
                "type": "treatmentSummary"
            },
            {
                "id": "PHP78316",
                "label": "Inflammatory bowel disease",
                "type": "treatmentSummary"
            },
            {
                "id": "PHP78375",
                "label": "Eczema and psoriasis, drugs affecting the immune response",
                "type": "treatmentSummary"
            },
            {
                "id": "PHP78421",
                "label": "Rheumatic disease, suppressing drugs",
                "type": "treatmentSummary"
            },
            {
                "id": "PHP78510",
                "label": "Neural tube defects (prevention in pregnancy)",
                "type": "treatmentSummary"
            },
            {
                "id": "PHP78524",
                "label": "Intravenous nutrition",
                "type": "treatmentSummary"
            },
            {
                "id": "PHP78590",
                "label": "Anaemias",
                "type": "treatmentSummary"
            }
        ]
    },
    "links": {
        "interaction": [
            {
                "id": "bnf_int_767",
                "label": "Folic Acid",
                "type": "interaction"
            }
        ],
        "#drugs": [
            {
                "id": "drugs",
                "label": "Drugs",
                "type": "#drugs"
            }
        ],
        "medicinalForm": [
            {
                "id": "PHP74744",
                "label": "Tablet",
                "type": "medicinalForm"
            },
            {
                "id": "PHP74751",
                "label": "Oral solution",
                "type": "medicinalForm"
            }
        ]
    }
}